4min chapter

We Study Billionaires - The Investor’s Podcast Network cover image

TIP528: Mastermind Q1 2023 w/ Tobias Carlisle and Hari Ramachandra

We Study Billionaires - The Investor’s Podcast Network

CHAPTER

Biotechs

Amgen is a company that I've owned on and off for a very long period of time. It's quantitatively cheap and they have this exceptional buyback record. In addition to the buybacks, the shareholder yield is monstrous. The strong dollar hurts companies like Amgen because it's priced as if revenues will decline permanently.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode